STEFANI VANSTON: Open Payments
NPI 1588049969 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 47 payments from 10 companies in 2025. Trend: 2023 $491 · 2024 $920 · 2025 $1,300
Food & beverage: $1,300
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 6 | $204 |
| Dexcom, Inc. | 3 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $161 |
| Amgen Inc. | 6 | $151 |
| Lilly USA, LLC | 9 | $142 |
| Novo Nordisk Inc | 5 | $114 |
| Medtronic, Inc. | 1 | $109 |
| Abbott Laboratories | 5 | $95 |
| Sequel Med Tech, LLC | 4 | $85 |
| Ascendis Pharma Endocrinology Inc | 1 | $77 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, JARDIANCE, TEPEZZA, MOUNJARO, MINIMED 780G, FREESTYLE LIBRE 3, TWIIST.
Industry payments across PA — which companies pay providers there.
